Bone Drugs

Is It Dangerous to Stop Taking Prolia?

By NWHN Staff | Apr 4, 2019 | Comments Off on Is It Dangerous to Stop Taking Prolia?

In clinical trials, results also suggest that people who stop taking Prolia and did not start another treatment experienced more vertebral fractures in the 10 months after treatment than people who had been taking a placebo. Researchers and physicians recommend that you do not stop taking Prolia without making a plan for further bone treatment.  

The Risks of Prolia As an Osteoporosis Treatment

By Evita Almassi | Dec 4, 2017 | Comments Off on The Risks of Prolia As an Osteoporosis Treatment

Prolia is a medication treatment option for people with osteoporosis. Prolia is a type of monoclonal antibody, which stops the natural breakdown of bones.

Is Ipriflavone Effective in Treating Osteoporosis?

By Ali Tweedt | May 26, 2017 | Comments Off on Is Ipriflavone Effective in Treating Osteoporosis?

Ipriflavone is an herbal medicine made from a hormone found in soy plants that has a similar chemical structure to human estrogen. Ipriflavone supplements are said to increase calcium absorption and decrease the breakdown of bones; however, there is currently a lack of research supporting this claim.    

Do Bone Drugs Lose Their Effectiveness?

By Shaniqua Seth | Nov 30, 2016 | Comments Off on Do Bone Drugs Lose Their Effectiveness?

I have been treated with Aclasta for the last four years. My doctor wants to switch me to Prolia. He told me research has shown that using the same drug reduces its effectiveness. Is it true that Aclasta may lose effectiveness over extended use?

Are “Scary Bone Drugs” Necessary to Prevent Fractures?

By NWHN Staff | Jul 13, 2016 | Comments Off on Are “Scary Bone Drugs” Necessary to Prevent Fractures?

The NWHN acknowledges the overbearing influence pharmaceutical companies have on doctors and patients. This issue arises for those diagnosed with high bone fracture risk. Women are specifically targeted since they’re five times more likely to be diagnosed than men.